[1]: Franceschi, C., & Campisi, J. (2014). Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. The Journals of Gerontology: Series A, 69(Suppl_1), S4-S9.
[2]: Furman, D., Campisi, J., Verdin, E., et al. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine, 25(12), 1822-1832.
[3]: Coppé, J. P., Desprez, P. Y., Krtolica, A., & Campisi, J. (2010). The senescence-associated secretory phenotype: the dark side of tumor suppression. Annual Review of Pathology: Mechanisms of Disease, 5, 99-118.
[4]: López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The hallmarks of aging. Cell, 153(6), 1194-1217.
[5]: Shaw, A. C., Goldstein, D. R., & Montgomery, R. R. (2013). Age-dependent dysregulation of innate immunity. Nature Reviews Immunology, 13(12), 875-887.
[6]: Biragyn, A., & Ferrucci, L. (2018). Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging. The Lancet Oncology, 19(6), e295-e304.
[7]: Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature, 444(7121), 860-867.
[8]: Irwin, M. R., & Cole, S. W. (2011). Reciprocal regulation of the neural and innate immune systems. Nature Reviews Immunology, 11(9), 625-632.
[9]: von Zglinicki, T. (2002). Oxidative stress shortens telomeres. Trends in Biochemical Sciences, 27(7), 339-344.
[10]: Hou, L., et al. (2015). Air pollution exposure and telomere length in highly exposed subjects in Beijing, China: a repeated-measure study. Environment International, 85, 96-103.
[11]: López-Otín et al., 2013. (同上)
[12]: Libby, P. (2002). Inflammation in atherosclerosis. Nature, 420(6917), 868-874.
[13]: Schaap, L. A., Pluijm, S. M., Deeg, D. J., & Visser, M. (2006). Inflammatory markers and loss of muscle mass (sarcopenia) and strength. The American Journal of Medicine, 119(6), 526-e9.
[14]: Heneka, M. T., Carson, M. J., El Khoury, J., et al. (2015). Neuroinflammation in Alzheimer's disease. The Lancet Neurology, 14(4), 388-405.
[15]: García-Prat, L., Martínez-Vicente, M., Perdiguero, E., et al. (2016). Autophagy maintains stemness by preventing senescence. Nature, 529(7584), 37-42.
[16]: Füllgrabe, J., Kavanagh, E., & Joseph, B. (2014). The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. Nature, 500(7463), 468-471.
[17]: Quach, A., Levine, M. E., Tanaka, T., et al. (2017). Epigenetic clock analysis of diet, exercise, education, and lifestyle factors. Aging, 9(2), 419.
[18]: Estruch, R., Ros, E., Salas-Salvadó, J., et al. (2018). Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine, 378(25), e34.
[19]: Calder, P. C. (2013). Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. British Journal of Clinical Pharmacology, 75(3), 645-662.
[20]: Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS Journal, 15(1), 195-218.
[21]: Petersen, A. M., & Pedersen, B. K. (2005). The anti-inflammatory effect of exercise. Journal of Applied Physiology, 98(4), 1154-1162.
[22]: Irwin, M. R. (2015). Why sleep is important for health: a psychoneuroimmunology perspective. Annual Review of Psychology, 66, 143-172.
[23]: Black, D. S., & Slavich, G. M. (2016). Mindfulness meditation and the immune system: a systematic review of randomized controlled trials. Annals of the New York Academy of Sciences, 1373(1), 13-24.
[24]: Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metabolism, 27(3), 529-547.
[25]: Cameron, A. R., Morrison, V. L., Levin, D., et al. (2016). Anti-inflammatory effects of metformin irrespective of diabetes status. Circulation Research, 119(5), 652-665.
[26]: Kirkland, J. L., & Tchkonia, T. (2020). Senolytic drugs: from discovery to translation. Journal of Internal Medicine, 288(5), 518-536.
封面报道|燃烧的火焰:慢性炎症——为何说衰老是一种炎症状态?
[27]: Ridker, P. M., Everett, B. M., Thuren, T., et al. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine, 377(12), 1119-1131.